List of Tables
    Table 1. Inhalers CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Inhalers Market Trends
    Table 3. Inhalers Market Drivers
    Table 4. Inhalers Market Challenges
    Table 5. Inhalers Market Restraints
    Table 6. Global Inhalers Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Inhalers Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Inhalers Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Inhalers Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Inhalers Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Inhalers Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Inhalers Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Inhalers Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Inhalers Sales Share by Manufacturer, 2017-2022
    Table 15. Global Inhalers Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Inhalers Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Inhalers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhalers as of 2021)
    Table 18. Top Players of Inhalers in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Inhalers Product Type
    Table 20. Date of International Manufacturers Enter into Inhalers Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Inhalers Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Inhalers Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Inhalers Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Inhalers Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Inhalers Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Inhalers Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Inhalers Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Inhalers Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Inhalers Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Inhalers Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Inhalers Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Inhalers Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Inhalers Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Inhalers Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Inhalers Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Inhalers Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Inhalers Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Inhalers Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Inhalers Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Inhalers Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. GlaxoSmithKline Corporation Information
    Table 43. GlaxoSmithKline Description and Business Overview
    Table 44. GlaxoSmithKline Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. GlaxoSmithKline Inhalers Product
    Table 46. GlaxoSmithKline Recent Development
    Table 47. Merck Corporation Information
    Table 48. Merck Description and Business Overview
    Table 49. Merck Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. Merck Product
    Table 51. Merck Recent Development
    Table 52. AstraZeneca Corporation Information
    Table 53. AstraZeneca Description and Business Overview
    Table 54. AstraZeneca Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. AstraZeneca Product
    Table 56. AstraZeneca Recent Development
    Table 57. Boehringer-Ingelheim Corporation Information
    Table 58. Boehringer-Ingelheim Description and Business Overview
    Table 59. Boehringer-Ingelheim Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. Boehringer-Ingelheim Product
    Table 61. Boehringer-Ingelheim Recent Development
    Table 62. 3M Corporation Information
    Table 63. 3M Description and Business Overview
    Table 64. 3M Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 65. 3M Product
    Table 66. 3M Recent Development
    Table 67. Teva Corporation Information
    Table 68. Teva Description and Business Overview
    Table 69. Teva Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 70. Teva Product
    Table 71. Teva Recent Development
    Table 72. Sunovion Pharmaceuticals Corporation Information
    Table 73. Sunovion Pharmaceuticals Description and Business Overview
    Table 74. Sunovion Pharmaceuticals Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 75. Sunovion Pharmaceuticals Product
    Table 76. Sunovion Pharmaceuticals Recent Development
    Table 77. Aristopharma Corporation Information
    Table 78. Aristopharma Description and Business Overview
    Table 79. Aristopharma Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 80. Aristopharma Product
    Table 81. Aristopharma Recent Development
    Table 82. Novartis Corporation Information
    Table 83. Novartis Description and Business Overview
    Table 84. Novartis Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 85. Novartis Product
    Table 86. Novartis Recent Development
    Table 87. Vectura Group Corporation Information
    Table 88. Vectura Group Description and Business Overview
    Table 89. Vectura Group Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 90. Vectura Group Product
    Table 91. Vectura Group Recent Development
    Table 92. MannKind Corporation Information
    Table 93. MannKind Description and Business Overview
    Table 94. MannKind Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 95. MannKind Product
    Table 96. MannKind Recent Development
    Table 97. Respirices Corporation Information
    Table 98. Respirices Description and Business Overview
    Table 99. Respirices Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 100. Respirices Product
    Table 101. Respirices Recent Development
    Table 102. Orion Pharm Corporation Information
    Table 103. Orion Pharm Description and Business Overview
    Table 104. Orion Pharm Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 105. Orion Pharm Product
    Table 106. Orion Pharm Recent Development
    Table 107. Hovione Corporation Information
    Table 108. Hovione Description and Business Overview
    Table 109. Hovione Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 110. Hovione Product
    Table 111. Hovione Recent Development
    Table 112. Key Raw Materials Lists
    Table 113. Raw Materials Key Suppliers Lists
    Table 114. Inhalers Customers List
    Table 115. Inhalers Distributors List
    Table 116. Research Programs/Design for This Report
    Table 117. Key Data Information from Secondary Sources
    Table 118. Key Data Information from Primary Sources
List of Figures
    Figure 1. Inhalers Product Picture
    Figure 2. Global Inhalers Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Inhalers Market Size 2017-2028 (US$ Million)
    Figure 4. Global Inhalers Sales 2017-2028 (K Units)
    Figure 5. United States Inhalers Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Inhalers Market Size 2017-2028 (US$ Million)
    Figure 7. United States Inhalers Sales 2017-2028 (K Units)
    Figure 8. United States Inhalers Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Inhalers Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Inhalers Report Years Considered
    Figure 11. Product Picture of Metered Dose Inhalers
    Figure 12. Product Picture of Dry Powder Inhalers
    Figure 13. Product Picture of Nasal Inhalers
    Figure 14. Product Picture of Other
    Figure 15. Global Inhalers Market Share by Type in 2022 & 2028
    Figure 16. Global Inhalers Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 17. Global Inhalers Sales Market Share in Value by Type (2017-2028)
    Figure 18. Global Inhalers Sales by Type (2017-2028) & (K Units)
    Figure 19. Global Inhalers Sales Market Share in Volume by Type (2017-2028)
    Figure 20. Global Inhalers Price by Type (2017-2028) & (USD/Unit)
    Figure 21. United States Inhalers Market Share by Type in 2022 & 2028
    Figure 22. United States Inhalers Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 23. United States Inhalers Sales Market Share in Value by Type (2017-2028)
    Figure 24. United States Inhalers Sales by Type (2017-2028) & (K Units)
    Figure 25. United States Inhalers Sales Market Share in Volume by Type (2017-2028)
    Figure 26. United States Inhalers Price by Type (2017-2028) & (USD/Unit)
    Figure 27. Product Picture of Hospital
    Figure 28. Product Picture of Clinic
    Figure 29. Product Picture of Respiratory Care Centers
    Figure 30. Product Picture of Others
    Figure 31. Global Inhalers Market Share by Application in 2022 & 2028
    Figure 32. Global Inhalers Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 33. Global Inhalers Sales Market Share in Value by Application (2017-2028)
    Figure 34. Global Inhalers Sales by Application (2017-2028) & (K Units)
    Figure 35. Global Inhalers Sales Market Share in Volume by Application (2017-2028)
    Figure 36. Global Inhalers Price by Application (2017-2028) & (USD/Unit)
    Figure 37. United States Inhalers Market Share by Application in 2022 & 2028
    Figure 38. United States Inhalers Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 39. United States Inhalers Sales Market Share in Value by Application (2017-2028)
    Figure 40. United States Inhalers Sales by Application (2017-2028) & (K Units)
    Figure 41. United States Inhalers Sales Market Share in Volume by Application (2017-2028)
    Figure 42. United States Inhalers Price by Application (2017-2028) & (USD/Unit)
    Figure 43. North America Inhalers Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 44. North America Inhalers Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 45. U.S. Inhalers Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Canada Inhalers Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Europe Inhalers Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 48. Europe Inhalers Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 49. Germany Inhalers Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. France Inhalers Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. U.K. Inhalers Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Italy Inhalers Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Russia Inhalers Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Asia-Pacific Inhalers Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 55. Asia-Pacific Inhalers Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 56. China Inhalers Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Japan Inhalers Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. South Korea Inhalers Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. India Inhalers Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Australia Inhalers Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Taiwan Inhalers Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Indonesia Inhalers Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Thailand Inhalers Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Malaysia Inhalers Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Philippines Inhalers Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Latin America Inhalers Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 67. Latin America Inhalers Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 68. Mexico Inhalers Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Brazil Inhalers Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Argentina Inhalers Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Middle East & Africa Inhalers Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 72. Middle East & Africa Inhalers Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 73. Turkey Inhalers Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Saudi Arabia Inhalers Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. UAE Inhalers Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 76. Inhalers Value Chain
    Figure 77. Inhalers Production Process
    Figure 78. Channels of Distribution
    Figure 79. Distributors Profiles
    Figure 80. Bottom-up and Top-down Approaches for This Report
    Figure 81. Data Triangulation
    Figure 82. Key Executives Interviewed